Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 333

1.
2.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
3.
4.

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

Biederman J, Wilens T, Mick E, Spencer T, Faraone SV.

Pediatrics. 1999 Aug;104(2):e20.

PMID:
10429138
7.
8.
9.

ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.

Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH.

Addict Behav. 2014 Jan;39(1):325-8. doi: 10.1016/j.addbeh.2013.09.002. Epub 2013 Sep 10.

PMID:
24090624
10.

Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.

Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, Biederman J.

Arch Pediatr Adolesc Med. 2008 Oct;162(10):916-21. doi: 10.1001/archpedi.162.10.916.

11.

Childhood stimulant treatment and risk for later substance abuse.

Fischer M, Barkley RA.

J Clin Psychiatry. 2003;64 Suppl 11:19-23.

12.

Does stimulant treatment lead to substance use disorders?

Faraone SV, Wilens T.

J Clin Psychiatry. 2003;64 Suppl 11:9-13.

13.

A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.

Faraone SV, Biederman J, Wilens TE, Adamson J.

Psychol Med. 2007 Dec;37(12):1743-52. Epub 2007 Mar 12.

PMID:
17349106
14.

When ADHD and substance use disorders intersect: relationship and treatment implications.

Wilens TE, Fusillo S.

Curr Psychiatry Rep. 2007 Oct;9(5):408-14. Review.

PMID:
17915081
16.
17.

A clinical perspective of attention-deficit/hyperactivity disorder into adulthood.

Wilens TE, Dodson W.

J Clin Psychiatry. 2004 Oct;65(10):1301-13. Review.

PMID:
15491232
18.

Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.

Guevara J, Lozano P, Wickizer T, Mell L, Gephart H.

Pediatrics. 2002 May;109(5):733-9.

PMID:
11986429
19.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
20.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
Items per page

Supplemental Content

Write to the Help Desk